Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Virology Journal|August 13, 2009
A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complementYuanyong Xu, Chuanfu Zhang, Leili Jia, et al.
The Journal of Biological Chemistry|October 13, 2016
Cell Entry of Porcine Epidemic Diarrhea Coronavirus Is Activated by Lysosomal ProteasesChang Liu, Yuanmei Ma, Yang Yang, et al.
Journal of Cellular and Molecular Medicine|June 11, 2014
Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signallingWenji Yan, Kongming Wu, James G Herman, et al.
Vaccine|March 5, 2015
A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length proteinJingjing Guo, Yi Yang, Wenjun Xiao, et al.
Scientific Reports|May 3, 2018
Up-regulation of microRNA-203 in influenza A virus infection inhibits viral replication by targeting DR1Sen Zhang, Jing Li, Junfeng Li, et al.
Journal of Virology|June 15, 2018
Design of Novel HIV-1/2 Fusion Inhibitors with High Therapeutic Efficacy in Rhesus Monkey ModelsHuihui Chong, Jing Xue, Yuanmei Zhu, et al.
Vaccine|February 25, 2014
Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccinesCuiqing Ma, Ye Li, Lili Wang, et al.
Cancer Letters|August 18, 2009
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinomaYao Chen, Yusen Zhou, Suimin Qiu, et al.
BMC Infectious Diseases|November 25, 2021
Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 yearsJia Li, Yali Zheng, Lili Zhao, et al.
Diabetes, Obesity & Metabolism|November 21, 2025
Efficacy and safety of bi-weekly cofrogliptin treatment replacing daily dipeptidyl peptidase-4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open-label, randomized controlled phase 2 trialCongqing Pan, Hongwei Jiang, Yi Feng, et al.
Pageof 15